---
$id: https://graph.org.ai/products/commodity/51111736
$type: Product
source: UNSPSC
code: "51111736"
title: "Cetuximab"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cetuximab

**UNSPSC Code**: 51111736
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoclonal antibody with the molecular formula C6484H10042N1732O2023S36, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PQX0D8J21J, more generally known as cetuximab. European Medicines Agency schedules cetuximab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01178MIG. The term CETUXIMAB is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 14, no. 3, 2000, list 44. Most nations schedule cetuximab under HS 30021091 and SITC 54163. As of Q4 2014, CETUXIMAB remains the US FDA Preferred Term for this commodity. Cetuximab bears US NLM identifiers UMLS ID C0995188 and NCI Concept Code C1723. SMILES: CC(=O)NC1C(C(C(OC1N)CO)O)O.

